
Star Health and Allied Insurance Q2 Results 2025 Highlights: Net Profit Falls by 50.67% & Revenue Up 10.18% YoY
Click and Sign Up to Get Live Updates on Q2 Results
Updated: 29 Oct 2025 • 2:41 pm
Posted by:

Star Health and Allied Insurance Q2 Results: Star Health and Allied Insurance revealed its Q2 results on 28th October 2025. In Q2 FY26, profit decreased by 50.67% YoY, and revenue increased by 10.18% YoY. The company posted substantial numbers, with Q2 PAT at ₹54.90 crores and revenue of ₹4,080.83 crores.
Star Health and Allied Insurance Q2 Results FY26: Extracts of FY25 & FY26
| Particulars | Standalone Figures | |
| 30th Sept 2025 | 30th Sept 2024 | |
| Revenue from Operations | ₹4,080.83 | ₹3,703.88 |
| Profit Before Tax (PBT) | ₹77.68 | ₹148.80 |
| Profit After Tax (PAT) | ₹54.90 | ₹111.29 |
Star Health and Allied Insurance Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Star Health and Allied Insurance clocked Q2 FY26 standalone revenue of ₹4,080.83 crores vs ₹3,703.88 crores.
- On the profit front, Star Health and Allied Insurance earned a standalone PAT of ₹54.90 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹111.29 crore.
- According to the standalone figures, Star Health and Allied Insurance's quarterly PAT decreased by 50.67% YoY, while revenue rose by 10.18% YoY.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
About Star Health and Allied Insurance Limited
Star Health and Allied Insurance Limited was established in 2006 and has its headquarters in Chennai, India. It is a public company in India that specialises in health, overseas medical insurance, and personal accident insurance. It is known as the first standalone health insurer in India and offers a wide range of plans for individuals, corporations, and families. The company provides an extensive network of over 14,000 hospitals with cashless facilities, in-house claims processing, and a focus on customer service through digital channels and 24/7 support.
Star Health and Allied Insurance Share Price Performance
On the opening bell on 29th October 2025, Star Health and Allied Insurance shares opened at ₹478.00 per share. However, the initial gains have since eroded, and Star Health and Allied Insurance shares are trading at ₹477.95 per share, lower than the opening price.
Star Health and Allied Insurance shares have delivered returns of -10.86% over the past year and -47.28% over the past five years. Over the maximum year, the Star Health and Allied Insurance share returned -47.28% to investors.
What Analysts Expect Post Q2 Results?
Star Health and Allied Insurance's strong Q2 results for FY26 have led analysts to expect its share price to trend higher in the coming years. According to analysts, Star Health and Allied Insurance's price could reach ₹550.30 per share in the upcoming year and, in a downside scenario, could hit ₹459.20 per share. However, one must ignore stock market volatility and invest in Star Health and Allied Insurance's shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Recent Articles

Power Stocks: Anand Rathi Sees Demand Cycle Shifting to Value, Flags Clean Max and ACME Solar
8 October 2026

AMFI Reclassification From February 2027: Six Stocks Including Bosch, Lenskart and LG Electronics Could Enter the Large-Cap Club, Says Nuvama
8 October 2026

Hotel Stocks to Buy Before Diwali 2026? JM Financial Sees 12-13% RevPAR Growth and Backs Leela, Lemon Tree and ITC Hotels
8 October 2026

Paytm Share Price Drops 5% to Rs 1,641.50 as UPI MDR Rollout May Slip to January 2027: What Brokerages Say
8 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Power Stocks: Anand Rathi Sees Demand Cycle Shifting to Value, Flags Clean Max and ACME Solar
AMFI Reclassification From February 2027: Six Stocks Including Bosch, Lenskart and LG Electronics Could Enter the Large-Cap Club, Says Nuvama
Hotel Stocks to Buy Before Diwali 2026? JM Financial Sees 12-13% RevPAR Growth and Backs Leela, Lemon Tree and ITC Hotels
Paytm Share Price Drops 5% to Rs 1,641.50 as UPI MDR Rollout May Slip to January 2027: What Brokerages Say
Physicswallah Share Price Jumps 41% in 2026 While Sensex Falls 8%: Is Motilal Oswal's Rs 200 Target Within Reach?
Popular this week
Sapphire Foods India (SAPPHIRE) Share Price Falls 5.09% as Mid Cap FMCG Stock Trades Lower

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





